Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1996 1
2000 1
2002 1
2005 1
2006 1
2007 2
2010 1
2011 1
2013 1
2016 4
2017 8
2018 3
2019 3
2021 3
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Larger and longer studies of the safety of ocrelizumab are required. (Funded by F. Hoffmann-La Roche; OPERA I and II ClinicalTrials.gov numbers, NCT01247324 and NCT01412333 , respectively.)....
Larger and longer studies of the safety of ocrelizumab are required. (Funded by F. Hoffmann-La Roche; OPERA I and II ClinicalTrials.g …
Microtubule-associated protein 1B: a neuronal binding partner for gigaxonin.
Ding J, Liu JJ, Kowal AS, Nardine T, Bhattacharya P, Lee A, Yang Y. Ding J, et al. J Cell Biol. 2002 Aug 5;158(3):427-33. doi: 10.1083/jcb.200202055. Epub 2002 Jul 29. J Cell Biol. 2002. PMID: 12147674 Free PMC article.
At least two different mutations identified in GAN patients (Bomont, P., L. Cavalier, F. Blondeau, C. Ben Hamida, S. Belal, M. Tazir, E. Demir, H. Topaloglu, R. ...
At least two different mutations identified in GAN patients (Bomont, P., L. Cavalier, F. Blondeau, C. Ben Hamida, S. Belal, M. …
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis: A Randomized, Phase 3, Clinical Trial.
Vermersch P, Brieva-Ruiz L, Fox RJ, Paul F, Ramio-Torrenta L, Schwab M, Moussy A, Mansfield C, Hermine O, Maciejowski M; AB07002 Study Group. Vermersch P, et al. Neurol Neuroimmunol Neuroinflamm. 2022 Feb 21;9(3):e1148. doi: 10.1212/NXI.0000000000001148. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35190477 Free PMC article. Clinical Trial.
High-performance liquid chromatographic determination of ciprofloxacin in plasma samples.
Vybíralová Z, Nobilis M, Zoulova J, Kvetina J, Petr P. Vybíralová Z, et al. J Pharm Biomed Anal. 2005 Apr 29;37(5):851-8. doi: 10.1016/j.jpba.2004.09.034. J Pharm Biomed Anal. 2005. PMID: 15862658
In previously published HPLC methods on conventional C18 reversed-phase [F. Belal, A.A. Al-Majed, A.M. Al-Obaid, Talanta 50 (1999) 765-786; G. ...
In previously published HPLC methods on conventional C18 reversed-phase [F. Belal, A.A. Al-Majed, A.M. Al-Obaid, Talanta 50 (1 …
Comparison of calcium and hydroxyl ion release ability and in vivo apatite-forming ability of three bioceramic-containing root canal sealers.
Belal RS, Edanami N, Yoshiba K, Yoshiba N, Ohkura N, Takenaka S, Noiri Y. Belal RS, et al. Clin Oral Investig. 2022 Feb;26(2):1443-1451. doi: 10.1007/s00784-021-04118-w. Epub 2021 Aug 16. Clin Oral Investig. 2022. PMID: 34398328
CONCLUSIONS: Ca(2+) and OH(-) release is ranked as follows: Endo-BC > MTA-F > N-BG. Only Endo-BC demonstrated in vivo apatite formation. CLINICAL RELEVANCE: Endo-BC could promote faster periapical healing than MTA-F and N-BG....
CONCLUSIONS: Ca(2+) and OH(-) release is ranked as follows: Endo-BC > MTA-F > N-BG. Only Endo-BC demonstrated in vivo apatite f …
Simultaneous estimation of recently FDA approved co-formulated ophthalmic solution benoxinate and fluorescein: Application to aqueous humor.
Saad Radwan A, Salim MM, Hadad GM, Belal F, Elkhoudary MM. Saad Radwan A, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2022 Feb 15;267(Pt 2):120599. doi: 10.1016/j.saa.2021.120599. Epub 2021 Nov 16. Spectrochim Acta A Mol Biomol Spectrosc. 2022. PMID: 34810099
The performance of the proposed methods was assessed relying on the correlation coefficients, relative standard deviations, and limits of detection and quantitation. The variance ratio F-test and Student t-test showed no significant differences between the obtained results …
The performance of the proposed methods was assessed relying on the correlation coefficients, relative standard deviations, and limits of de …
Eco-friendly simultaneous multi-spectrophotometric estimation of the newly approved drug combination of celecoxib and tramadol hydrochloride tablets in its dosage form.
Ramadan HS, Salam RAA, Hadad GM, Belal F, Salim MM. Ramadan HS, et al. Sci Rep. 2023 Jul 20;13(1):11716. doi: 10.1038/s41598-023-38702-9. Sci Rep. 2023. PMID: 37474596 Free PMC article.
The obtained results revealed non-significant differences compared to the reported results as revealed by the variance ratio F test and Student t test. Moreover, the applied techniques were further assessed concerning their greenness based on the analytical eco-scale metho …
The obtained results revealed non-significant differences compared to the reported results as revealed by the variance ratio F test a …
36 results